Complement regulates inhalation tolerance at the dendritic cell/T cell interface

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 44-56

  Köhl, Jörg ^a   Wills Karp, Marsha ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Asthma; C5a; Complement; Dendritic cell; Regulatory T cell; Tolerance

Indexed keywords

COMPLEMENT COMPONENT C5;

ALLERGIC ASTHMA; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL SUBPOPULATION; CELL SURVIVAL; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INHALATION; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SENSITIZATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ALLERGENS; ANIMALS; ASTHMA; COMPLEMENT ACTIVATION; COMPLEMENT C5; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DENDRITIC CELLS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE TOLERANCE; INHALATION EXPOSURE; LUNG; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, PATTERN RECOGNITION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 33750488768     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.016     Document Type: Article

References (124)

1. Abe M., Shibata K., Akatsu H., Shimizu N., Sakata N., Katsuragi T., and Okada H. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J. Immunol. 167 (2001) 4651-4660
2. Akbari O., DeKruyff R.H., and Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2 (2001) 725-731
3. Akbari O., Freeman G.J., Meyer E.H., Greenfield E.A., Chang T.T., Sharpe A.H., Berry G., DeKruyff R.H., and Umetsu D.T. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8 (2002) 1024-1032
4. Ames R.S., Li Y., Sarau H.M., Nuthulaganti P., Foley J.J., Ellis C., Zeng Z., Su K., Jurewicz A.J., Hertzberg R.P., Bergsma D.J., and Kumar C. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271 (1996) 20231-20234
5. Anon., 1997. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat. Genet. 15, 389-392.
6. Baelder R., Fuchs B., Bautsch W., Zwirner J., Köhl J., Hoymann H.G., Glaab T., Erpenbeck V., Krug N., and Braun A. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J. Immunol. 174 (2005) 783-789
7. Barnes K.C., Grant A.V., Baltadzhieva D., Zhang S., Berg T., Shao L., Zambelli-Weiner A., Anderson W., Nelsen A., Pillai S., Yarnall D.P., Dienger K., Ingersoll R.G., Scott A.F., Fallin M.D., Mathias R.A., Beaty T.H., Garcia J.G., and Wills-Karp M. Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families. Genes Immun. 7 (2006) 27-35
8. Bautsch W., Hoymann H.G., Zhang Q., Meier-Wiedenbach L., Raschke U., Ames R.S., Sohns B., Flemme N., Meyer Z.V., Grove M., Klos A., and Köhl J. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J. Immunol. 165 (2000) 5401-5405
9. Bito L.Z. Inflammatory effects of endotoxin-like contaminants in commonly used protein preparations. Science 196 (1977) 83-85
10. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440 (2006) 808-812
11. Boulay F., Mery L., Tardif M., Brouchon L., and Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30 (1991) 2993-2999
12. Cain S.A., and Monk P.N. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277 (2002) 7165-7169
13. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197 (2003) 403-411
14. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 5 (2004) 981-986
15. Castro F.F., Schmitz Schumann M., Rother U., and Kirschfink M. Complement activation by house dust: reduced reactivity of serum complement in patients with bronchial asthma. Int. Arch. Allergy Appl. Immunol. 96 (1991) 305-310
16. Chen M., Wang Y.H., Wang Y., Huang L., Sandoval H., Liu Y.J., and Wang J. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311 (2006) 1160-1164
17. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5 (2004) 1219-1226
18. Colten H.R., and Strunk R.C. Synthesis of complement components in liver and at extraheptic sites. In: Whaley K., Loos M., and Weiler J.M. (Eds). Complement in Health and Disease (1993), Kluwer Academic Publishers, Dordrecht 127-158
19. Constant S.L., Brogdon J.L., Piggott D.A., Herrick C.A., Visintin I., Ruddle N.H., and Bottomly K. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110 (2002) 1441-1448
20. Crass T., Raffetseder U., Martin U., Grove M., Klos A., Köhl J., and Bautsch W. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26 (1996) 1944-1950
21. Dahl M.E., Dabbagh K., Liggitt D., Kim S., and Lewis D.B. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat. Immunol. 5 (2004) 337-343
22. De Heer H.J., Hammad H., Soullie T., Hijdra D., Vos N., Willart M.A., Hoogsteden H.C., and Lambrecht B.N. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200 (2004) 89-98
23. Devlin R.B., McDonnell W.F., Becker S., Madden M.C., McGee M.P., Perez R., Hatch G., House D.E., and Koren H.S. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 h: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 h after exposure. Toxicol. Appl. Pharmacol. 138 (1996) 176-185
24. Drouin S.M., Corry D.B., Hollman T.J., Kildsgaard J., and Wetsel R.A. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 169 (2002) 5926-5933
25. Drouin S.M., Corry D.B., Kildsgaard J., and Wetsel R.A. Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 167 (2001) 4141-4145
26. Drouin S.M., Kildsgaard J., Haviland J., Zabner J., Jia H.P., McCray P.B., Tack B.F., and Wetsel R.A. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J. Immunol. 166 (2001) 2025-2032
27. Drouin S.M., Sinha M., Sfyroera G., Lambris J.D., and Wetsel R.A. A protective role for the fifth complement component (c5) in allergic airway disease. Am. J. Respir. Crit Care Med. 173 (2006) 852-857
28. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., and Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196 (2002) 1645-1651
29. Elward K., Griffiths M., Mizuno M., Harris C.L., Neal J.W., Morgan B.P., and Gasque P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280 (2005) 36342-36354
30. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
31. Garlanda C., Bottazzi B., Bastone A., and Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23 (2005) 337-366
32. Gavett S.H., O'Hearn D.J., Li X., Huang S.K., Finkelman F.D., and Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182 (1995) 1527-1536
33. Gerard N.P., and Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 349 (1991) 614-617
34. Gerard N.P., Lu B., Liu P., Craig S., Fujiwara Y., Okinaga S., and Gerard C. An anti-inflammatory function for the complement anaphylatoxin C5a binding protein, C5L2. J. Biol. Chem. (2005)
35. Ghebrehiwet B., Randazzo B.P., Dunn J.T., Silverberg M., and Kaplan A.P. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J. Clin. Invest. 71 (1983) 1450-1456
36. Godau J., Heller T., Hawlisch H., Trappe M., Howells E., Best J., Zwirner J., Verbeek J.S., Hogarth P.M., Gerard C., Van Rooijen N., Klos A., Gessner J.E., and Köhl J. C5a initiates the inflammatory cascade in immune complex peritonitis. J. Immunol. 173 (2004) 3437-3445
37. Guo R.F., and Ward P.A. Role of c5ain inflammatory responses. Annu. Rev. Immunol. 23 (2005) 821-852
38. Hadeiba H., and Locksley R.M. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J. Immunol. 170 (2003) 5502-5510
39. Hammad H., Smits H.H., Ratajczak C., Nithiananthan A., Wierenga E.A., Stewart G.A., Jacquet A., Tonnel A.B., and Pestel J. Monocyte-derived dendritic cells exposed to Der p1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22. Eur. Cytokine Netw. 14 (2003) 219-228
40. Hansen G., Berry G., DeKruyff R.H., and Umetsu D.T. Allergen-specific Thl cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103 (1999) 175-183
41. Hasegawa K., Tamari M., Shao C., Shimizu M., Takahashi N., Mao X.Q., Yamasaki A., Kamada F., Doi S., Fujiwara H., Miyatake A., Fujita K., Tamura G., Matsubara Y., Shirakawa T., and Suzuki Y. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. Hum. Genet. 115 (2004) 295-301
42. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 (2001) 769-779
43. Hawlisch H., Belkaid Y., Baelder R., Hildeman D., Gerard C., and Köhl J. C5a negatively regulates Toll-like receptor 4-induced immune responses. Immunity 22 (2005) 415-426
44. Hawlisch H., and Köhl J. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol. Immunol. 43 (2006) 13-21
45. Hawlisch H., Wills-Karp M., Karp C.L., and Köhl J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 41 (2004) 123-131
46. Heaton T., Rowe J., Turner S., Aalberse R.C., de Klerk N., Suriyaarachchi D., Serralha M., Holt B.J., Hollams E., Yerkovich S., Holt K., Sly P.D., Goldblatt J., Le Souef P., and Holt P.G. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 365 (2005) 142-149
47. Herrick C.A., and Bottomry K. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3 (2003) 405-412
48. Holt P.G., Schon-Hegrad M.A., Oliver J., Holt B.J., and McMenamin P.G. A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium. Int. Arch. Allergy Appl. Immunol. 91 (1990) 155-159
49. Holt P.G., and Upham J.W. The role of dendritic cells in asthma. Curr. Opin. Allergy Clin. Immunol. 4 (2004) 39-44
50. Huber-Lang M., Younkin E.M., Sarma J.V., Riedemann N., McGuire S.R., Lu K.T., Kunkel R., Younger J.G., Zetoune F.S., and Ward P.A. Generation of C5aby phagocytic cells. Am. J. Pathol. 161 (2002) 1849-1859
51. Humbles A.A., Lu B., Nilsson C.A., Lilly C., Israel E., Fujiwara Y., Gerard N.P., and Gerard C. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406 (2000) 998-1001
52. Jaffar Z., Sivakuru T., and Roberts K. CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J. Immunol. 172 (2004) 3842-3849
53. Kadowaki N., Antonenko S., Lau J.Y., and Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192 (2000) 219-226
54. Kanemitsu H., Nagasawa S., Sagai M., and Mori Y. Complement activation by diesel exhaust particles (DEP). Biol. Pharm. Bull. 21 (1998) 129-132
55. Kang Y.S., Do Y., Lee H.K., Park S.H., Cheong C., Lynch R.M., Loeffler J.M., Steinman R.M., and Park C.G. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 125 (2006) 47-58
56. Karp C.L., Grupe A., Schadt E., Ewart S.L., Keane-Moore M., Cuomo P.J., Köhl J., Wahl L., Kuperman D., Germer S., Aud D., Peltz G., and Wills-Karp M. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1 (2000) 221-226
57. Keane-Myers A., Wysocka M., Trinchieri G., and Wills-Karp M. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12. J. Immunol. 161 (1998) 919-926
58. Khirwadkar K., Zilow G., Oppermann M., Kabelitz D., and Rother K. Interleukin-4 augments production of the third complement component by the alveolar epithelial cell line A549. Int. Arch. Allergy Immunol. 100 (1993) 35-41
59. Kim A.H., Dimitriou I.D., Holland M.C., Mastellos D., Mueller Y.M., Altman J.D., Lambris J.D., and Katsikis P.D. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J. Immunol. 173 (2004) 2524-2529
60. Kirchhoff K., Weinmann O., Zwirner J., Begemann G., Gotze O., Kapp A., and Werfel T. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Immunology 103 (2001) 210-217
61. Klein M.A., Kaeser P.S., Schwarz P., Weyd H., Xenarios J., Zinkernagel R.M., Carroll M.C., Verbeek J.S., Botto M., Walport M.J., Molina H., Kalinke U., Acha-Orbea H., and Aguzzi A. Complement facilitates early prion pathogenesis. Nat. Med. 7 (2001) 488-492
62. Köhl J. The role of complement in danger sensing and transmission. Immunol. Res. 34 (2006) 157-176
63. Köhl J. Anaphylatoxins and infectious and non-infectious inflammatory diseases. Mol. Immunol. 38 (2001) 175-187
64. Köhl J., Baelder R., Lewkowich I.P., Pandey M.K., Hawlisch H., Wang L., Best J., Herman N.S., Sproles A.A., Zwirner J., Whitsett J.A., Gerard C., Sfyroera G., Lambris J.D., and Wills-Karp M. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116 (2006) 783-796
65. Kovacsovics T., Tschopp J., Kress A., and Isliker H. Antibody-independent activation of C1, the first component of complement, by cardiolipin. J. Immunol. 135 (1985) 2695-2700
66. Krug N., Tschernig T., Erpenbeck V.J., Hohlfeld J.M., and Köhl J. Complement factors c3a and c5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am. J. Respir. Crit Care Med. 164 (2001) 1841-1843
67. Lambrecht B.N., De Veerman M., Coyle A.J., Gutierrez-Ramos J.C., Thielemans K., and Pauwels R.A. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106 (2000) 551-559
68. Lewkowich I.P., Herman N.S., Schleifer K.W., Dance M.P., Chen B.L., Dienger K.M., Sproles A.A., Shah J.S., Köhl J., Belkaid Y., and Wills-Karp M. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202 (2005) 1549-1561
69. Liu J., Miwa T., Hilliard B., Chen Y., Lambris J.D., Wells A.D., and Song W.C. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201 (2005) 567-577
70. Liu Y., Endo Y., Iwaki D., Nakata M., Matsushita M., Wada I., Inoue K., Munakata M., and Fujita T. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J. Immunol. 175 (2005) 3150-3156
71. Lloyd C.M., and Rankin S.M. Chemokines in allergic airway disease. Curr. Opin. Pharmacol. 3 (2003) 443-448
72. Lloyd C.M., Delaney T., Nguyen T., Tian J., Martinez A., Coyle A.J., and Gutierrez-Ramos J.C. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J. Exp. Med. 191 (2000) 265-274
73. Marc M.M., Korosec P., Kosnik M., Kern L., Flezar M., Suskovic S., and Sorli J. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma. Am. J. Respir. Cell Mol. Biol. 31 (2004) 216-219
74. Maruo K., Akaike T., Ono T., Okamoto T., and Maeda H. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease. J. Allergy Clin. Immunol. 100 (1997) 253-260
75. McWilliam A.S., Napoli S., Marsh A.M., Pemper F.L., Nelson D.J., Pimm C.L., Stumbles P.A., Wells T.N., and Holt P.G. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184 (1996) 2429-2432
76. Morelli A., Larregina A., Chuluyan E., Kolkowski E., and Fainboim L. Functional expression and modulation of C5a receptor (CD88) on skin dendritic cells. Adv. Exp. Med. Biol. 417 (1997) 133-138
77. Morelli A., Larregina A., Chuluyan L., Kolkowski E., and Fainboim L. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Immunology 89 (1996) 126-134
78. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989) 145-173
79. Nagata S., and Glovsky M.M. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation. J. Allergy Clin. Immunol. 80 (1987) 24-32
80. Neff T.A., Guo R.F., Neff S.B., Sarma J.V., Speyer C.L., Gao H., Bernacki K.D., Huber-Lang M., McGuire S., Hoesel L.M., Riedemann N.C., Beck-Schimmer B., Zetoune F.S., and Ward P.A. Relationship of acute lung inflammatory injury to Fas/FasL system. Am. J. Pathol. 166 (2005) 685-694
81. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., and Henson P.M. Clq and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194 (2001) 781-795
82. Ohno M., Hirata T., Enomoto M., Araki T., Ishimaru H., and Takahashi T.A. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol. Immunol. 37 (2000) 407-412
83. Okinaga S., Slattery D., Humbles A., Zsengeller Z., Morteau O., Kinrade M.B., Brodbeck R.M., Krause J.E., Choe H.R., Gerard N.P., and Gerard C. C5L2, a nonsignaling C5A binding protein. Biochemistry 42 (2003) 9406-9415
84. Oriss T.B., Ostroukhova M., Seguin-Devaux C., Dixon-McCarthy B., Stolz D.B., Watkins S.C., Pillemer B., Ray P., and Ray A. Dynamics of dendritic cell phenotype and interactions with CD4+ T cells in airway inflammation and tolerance. J. Immunol. 174 (2005) 854-863
85. Pangburn M.K., Schreiber R.D., and Muller-Eberhard H.J. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp. Med. 154 (1981) 856-867
86. Park J.W., Taube C., Joetham A., Takeda K., Kodama T., Dakhama A., McConville G., Allen C.B., Sfyroera G., Shultz L.D., Lambris J.D., Giclas P.C., Holers V.M., and Gelfand E.W. Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am. J. Respir. Crit Care Med. 169 (2004) 726-732
87. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
88. Peitsch M.C., Tschopp J., Kress A., and Isliker H. Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin. Biochem. J. 249 (1988) 495-500
89. Peng T., Hao L., Madri J.A., Su X., Elias J.A., Stahl G.L., Squinto S., and Wang Y. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J. Clin. Invest. 115 (2005) 1590-1600
90. Penna G., Vulcano M., Roncari A., Facchetti F., Sozzani S., and Adorini L. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J. Immunol. 169 (2002) 6673-6676
91. Piggott D.A., Eisenbarth S.C., Xu L., Constant S.L., Huleatt J.W., Herrick C.A., and Bottomly K. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J. Clin. Invest. 115 (2005) 459-467
92. Riese R.J., Finn P.W., and Shapiro S.D. Influenza and asthma: adding to the respiratory burden. Nat. Immunol. 5 (2004) 243-244
93. Robbins R.A., Nelson K.J., Gossman G.L., Koyama S., and Rennard S.I. Complement activation by cigarette smoke. Am. J. Physiol. 260 (1991) L254-L259
94. Rook G.A., and Brunet L.R. Microbes, immunoregulation, and the gut. Gut 54 (2005) 317-320
95. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
96. Schwartz L.B., Kawahara M.S., Hugli T.E., Vik D., Fearon D.T., and Austen K.F. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J. Immunol. 130 (1983) 1891-1895
97. Shima M., and Adachi M. Effects of environmental tobacco smoke on serum levels of acute phase proteins in schoolchildren. Prev. Med. 25 (1996) 617-624
98. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
99. Shushakova N., Skokowa J., Schulman J., Baumann U., Zwirner J., Schmidt R.E., and Gessner J.E. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J. Clin. Invest. 110 (2002) 1823-1830
100. Soruri A., Kiafard Z., Dettmer C., Riggert J., Köhl J., and Zwirner J. IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo. J. Immunol. 170 (2003) 3306-3314
101. Soruri A., Riggert J., Schlott T., Kiafard Z., Dettmer C., and Zwirner J. Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNF-alpha and prostaglandin E2-dependent mechanisms. J. Immunol. 171 (2003) 2631-2636
102. Sporri R., and Reise Sousa. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6 (2005) 163-170
103. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
104. Steinman R.M., and Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 351-358
105. Stimler-Gerard N.P. Role of the complement anaphylatoxins in inflammation and hypersensitivity reactions in the lung. Surv. Synth. Pathol. Res. 4 (1985) 423-442
106. Stock P., Akbari O., Berry G., Freeman G.J., DeKruyff R.H., and Umetsu D.T. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5 (2004) 1149-1156
107. Storrs S.B., Kolb W.P., and Olson M.S. Clq binding and Cl activation by various isolated cellular membranes. J. Immunol. 131 (1983) 416-422
108. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., and Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159 (1997) 1739-1745
109. Suto A., Nakajima H., Kagami S.L., Suzuki K., Saito Y., and Iwamoto I. Role of CD4(+) CD25(+) regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am. J. Respir. Crit Care Med. 164 (2001) 680-687
110. Taube C., Thurman J.M., Takeda K., Joetham A., Miyahara N., Carroll M.C., Dakhama A., Giclas P.C., Holers V.M., and Gelfand E.W. Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8084-8089
111. Thornton A.M., and Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164 (2000) 183-190
112. Tsitoura D.C., DeKruyff R.H., Lamb J.R., and Umetsu D.T. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J. Immunol. 163 (1999) 2592-2600
113. Turner M.W. The role of mannose-binding lectin in health and disease. Mol. Immunol. 40 (2003) 423-429
114. Walters D.M., Breysse P.N., Schofield B., and Wills-Karp M. Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 27 (2002) 413-418
115. Wannemuehler M.J., Kiyono H., Babb J.L., Michalek S.M., and McGhee J.R. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J. Immunol. 129 (1982) 959-965
116. Wetsel R.A., Fleischer D.T., and Haviland D.L. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J. Biol. Chem. 265 (1990) 2435-2440
117. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202 (2004) 175-190
118. Wills-Karp M., and Ewart S.L. Time to draw breath: asthma-susceptibility genes are identified. Nat. Rev. Genet. 5 (2004) 376-387
119. Wills-Karp M., and Köhl J. New insights into the role of the complement pathway in allergy and asthma. Curr. Allergy Asthma Rep. 5 (2005) 362-369
120. Wills-Karp M., Santeliz J., and Karp C.L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1 (2001) 69-75
121. Yang D., Chen Q., Stoll S., Chen X., Howard O.M., and Oppenheim J.J. Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression. J. Immunol. 165 (2000) 2694-2702
122. Zimmermann T., Laszik Z., Nagy S., Kaszaki J., and Joo F. The role of the complement system in the pathogenesis of multiple organ failure in shock. Prog. Clin. Biol. Res. 308 (1989) 291-297
123. Zuany-Amorim C., Sawicka E., Manlius C., Le Moine A., Brunet L.R., Kemeny D.M., Bowen G., Rook G., and Walker C. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8 (2002) 625-629
124. Zuniga E.I., McGavern D.B., Pruneda-Paz J.L., Teng C., and Oldstone M.B. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat. Immunol. 5 (2004) 1227-1234